Home › Geographic Atrophy › Maryland
Geographic Atrophy clinical trials in Maryland
7 studies for Geographic Atrophy are looking for participants at sites in Maryland.
Cities in Maryland
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Specialists, Baltimore
- The Retina Group of Washington, Chevy Chase
- Cumberland Valley Retina Consultants, Hagerstown
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
- Johns Hopkins University, Baltimore
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 55 to 95 · All sexes · Updated Sep 29, 2026 · NCT04339764A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- The Retina Group of Washington - Chevy Chase- Site Number : 8400009, Chevy Chase
- Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003, Hagerstown
- Retina Specialist- Site Number : 8400055, Towson
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study in Adults With Geographic Atrophy
- Cumberland Valley Retina Consultants,P.C., Hagerstown
- Mid Atlantic Retina Specialists, Hagerstown
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- The Retina Care Center, Baltimore
- The Retina Group of Washington, Chevy Chase
- Cumberland Valley Retina Consultants-Ophthalmology, Hagerstown
- and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- The Retina Care Center, Baltimore
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- The Retina Group of Washington, Chevy Chase
- Cumberland Valley Retina Consultants, Hagerstown
- Retina Specialists, Towson
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.